Navigation Links
Par Pharmaceutical Begins Shipment of Generic Zyprexa® Zydis®
Date:10/24/2011

ts higher-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press releases and other company information, visit www.parpharm.com.

Safe Harbor Statement

Certain statements in this news release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. To the extent any statements made in this news release contain information that is not historical, these statements are essentially forward looking and, as such, are subject to known and unknown risks, uncertainties and contingencies, many of which are beyond the control of the Company, which could cause actual results and outcomes to differ materially from those expressed herein. Risk factors that might affect such forward-looking statements include those set forth in Item 1A of the Company's most recent Annual Report on Form 10-K, in other of the Company's filings with the SEC from time to time, including Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and on general industry and economic conditions. Any forward-looking statements included in this news release are made as of the date hereof only, based on information available to the Company as of the date hereof, and, subject to any applicable law to the contrary, the Company assumes no obligation to update any forward-looking statements.


'/>"/>
SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014  BioSpecifics Technologies Corp. (NASDAQ: ... class collagenase-based products marketed as XIAFLEX ® in the ... that BioSpecifics, President, Tom Wegman , will present a ... in the Biotech Industry Conference. The presentation ... p.m. EDT at the Millennium Broadway Hotel in ...
(Date:9/19/2014)... 2014 Aufgrund der enormen ... erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der jetzt auch die Jahre ... unter pharmaserialisation.com , zeigt die Serialisierungsanforderungen weltweit ... Kraft treten. Für international tätige Unternehmen ... das "ob", sondern darum, "wann" sie die neu ...
(Date:9/19/2014)... -- Intarcia Therapeutics, Inc. today announced the ... candidate ITCA 650 (continuous subcutaneous delivery of exenatide) in ... at the 50 th Annual Meeting of the ... from the open-label, phase 3 FREEDOM-HBL (high baseline) trial ... with poorly controlled type 2 diabetes. The results were ...
Breaking Medicine Technology:BioSpecifics Technologies Corp. to Present at the 21st Annual BioCentury NewsMakers in the Biotech Industry Conference 2Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4
... 6, 2011 This is being released by SCM: ... weeks of testimony and 4 hours of closing statements, lead ... in Clark County Nevada, Robert Eglet, asked jurors to bring ... Arnold, $2.5 million in compensatory damages for James Arnold and ...
... the peer-reviewed publication of unique pre-clinical data on TIGR ® ... long-term absorbable surgical mesh. The study, which was presented ... Journal of Hernia and Abdominal Wall Surgery , describes the results of ... Matrix versus a permanent mesh in a sheep model. ...
Cached Medicine Technology:Lead Trial Attorney in Clark County Hepatitis C Trial, Robert Eglet, Asks Jury to Award $10 Million Compensatory Damages for Anne Arnold, $2.5 Million for James Arnold 2Hernia Publishes a Unique Three Year Pre-Clinical Study of absorbable TIGR® Matrix Surgical Mesh Versus a Permanent Mesh 2
(Date:9/21/2014)... 2014 (HealthDay News) -- Young women starting college understand ... foods they should eat. But they aren,t confident they ... to a new study. The study involved ... Illinois,s Peer Education Exercising and Eating Right program. The ... choose to eat if they were very busy with ...
(Date:9/21/2014)... 2014 Discount-Dress.com, a company ... recently announced its decision to implement a new shopping ... for ladies across the world. Furthermore, the company has ... ladies. , The new items come in fashionable ... prices, up to 56 percent off. "We are happy ...
(Date:9/21/2014)... September 21, 2014 Market ... (CAS 49562-28-9) Industry, 2009-2019 is a professional ... Chinese Fenofibrate (CAS 49562-28-9) industry. The report ... (CAS 49562-28-9) including its classification, application and ... China’s top manufacturers of Fenofibrate (CAS 49562-28-9) ...
(Date:9/21/2014)... del Rio, Colorado (PRWEB) September 21, 2014 ... Vail, Colorado, ten teams of disabled and able-bodied athletes ... cycles, and completed a ropes course in pursuit of ... Challenge from national non-profit World T.E.A.M. Sports, disabilities ... participating athletes who successfully completed the three stage event. ...
(Date:9/21/2014)... An experienced review website in the global market, Top10BestSEOHosting.com, ... announced that FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ), GoDaddy and Bluehost ... has been a boom in websites in recent years, ... in the number of web hosting companies that offer ... VPS (Virtual Private Server) is the method of partitioning ...
Breaking Medicine News(10 mins):Health News: College Women Can Use Food Strategies, Study Finds 2Health News:Discount-Dress.com Implements A New Shopping Cart Software And Provides New Beach Wedding Dresses 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 3Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 4Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 2Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 3Health News:Top10BestSEOHosting.com: FatCow, GoDaddy And Bluehost Are The Best VPS Hosting Suppliers 2
... KENSINGTON, Md., Sept. 8 The first-ever New Jersey Psoriasis ... 2009, at beautiful Van Saun Park. The walk, to ... Cure Now, will include entertainment, information booths on psoriasis treatments, ... with psoriasis and psoriatic arthritis. Janine Natoli of Little ...
... improves sleep quality in menopausal women with hot flashes, ... in the September issue of the Journal of ... women experience sleep disruption, often in the form of ... study is the first to show sustained benefits in ...
... , Sponsored by Chester County Eye ... WEST CONSHOHOCKEN, Pa., Sept. 8 Chester County Eye Care ... a SupportSight seminar in West Chester on September 26th. ... affected by macular degeneration and for those who would like to learn ...
... , , PITTSBURGH, Sept. 8 ... in toothpaste - new iso-active(R) Foaming Gel. Iso-active has a ... areas of the mouth. , , According to ... much of their tooth surface is actually hidden between the teeth. ...
... , MEXICO CITY, Sept. 8 ... "the Company"), one of the fastest,growing pharmaceutical and personal care ... today revisions to its,earnings guidance for the full year of ... 35%-38% and an EBITDA margin of approximately 25%. , ...
... in place, rates barely budge, report finds , TUESDAY, ... campaigns and widespread agreement about the importance of colorectal ... be screened do so, new research finds. , Rates ... lower still, with only 22 percent of lower-income people ...
Cached Medicine News:Health News:First-Ever NJ Psoriasis Walk Coming to Paramus on Sept. 12 2Health News:Seizure drug enhances sleep for women with hot flashes 2Health News:SupportSight Comes to West Chester, Saturday, September 26th; Free Seminar for Those Affected by Macular Degeneration 2Health News:New Gel Technology Reaches Hidden Areas of the Mouth 2Health News:New Gel Technology Reaches Hidden Areas of the Mouth 3Health News:Genomma Lab Internacional Revises 2009 Earnings Guidance 2Health News:Colon Cancer Screenings Still Too Low: Study 2Health News:Colon Cancer Screenings Still Too Low: Study 3
... The ORTHOSTAR table is the ... today. It was designed for ... body traction with an integrated ... a special purpose operating table ...
... is restricted. Due to its excellent drive ... every situation. For many complicated surgery positions, ... on the JUPITER during the induction to ... the high level of stability of JUPITER ...
... The mobile universal operating table ... table top allows for unlimited C-arm ... comfort for both neurosurgical and cardiovascular ... need for floor support can easily ...
... carbon fiber c-arm table allows 50 ... brachytherapy, gynecology, gastroenterology, cardiovascular, orthopedic, ENT, ... design allows easy access for all ... 16-inch elevating travel, 16-inch longitudinal travel, ...
Medicine Products: